ExploreWatchlistsPricing
  1. JP-listed companies
  2. SATO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Gross margin (%)

SATO PHARMACEUTICAL CO.,LTD. (E00954)

Market cap
P/E ratio
Sato Pharmaceutical develops and sells over-the-counter medicines, prescription drugs, and health products to consumers and medical institutions globally.
SummaryFinancialsDividendsHistorySegmentsWorkforce
Period EndGross margin (%) YoY (%)
Jul 31, 202357.2+0.66%
Jul 31, 202256.8-2.14%
Jul 31, 202158.1-2.04%
Jul 31, 202059.3-2.77%
Jul 31, 201961+0.48%
Jul 31, 201860.7-1.98%
Jul 31, 201761.9-2.03%
Jul 31, 201663.2-1.73%
Jul 31, 201564.3-1.39%
Jul 31, 201465.2

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat